Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis

BACKGROUND: Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2 infection, morbidity, and mortality compared to the general population. They should be prioritized for primary prevention through vaccination. This study aimed to evaluate the efficacy of COVID-19 mRNA vaccines in IC...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrabi Nejad, Mohammad-Mehdi, Moosaie, Fatemeh, Dehghanbanadaki, Hojat, Haji Ghadery, Abdolkarim, Shabani, Mahya, Tabary, Mohammadreza, Aryannejad, Armin, SeyedAlinaghi, SeyedAhmad, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840778/
https://www.ncbi.nlm.nih.gov/pubmed/35151362
http://dx.doi.org/10.1186/s40001-022-00648-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840778/
https://www.ncbi.nlm.nih.gov/pubmed/35151362
http://dx.doi.org/10.1186/s40001-022-00648-5

Ejemplares similares